Not Yet Recruiting OBSERVATIONAL NCT06773806
CHLORDECONE EXPOSURE AND PROSTATE CANCER IN THE FRENCH REGION OF MARTINIIQUE (CHLOECAPA)
LIEN ENTRE EXPOSITION A LA CHLORDECONE ET CANCER DE LA PROSTATE EN MARTINIQUE
Sponsor: Direction Générale de la Santé, France
Conditions
Prostate Cancer
Updated 2 times since 2025 Last updated: Sep 16, 2025 Started: Dec 31, 2025 Primary completion: Dec 31, 2028 Completion: Dec 31, 2028
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.
A observational or N/A phase clinical study on Prostate Cancer, this trial is actively recruiting participants. The trial is conducted by Direction Générale de la Santé, France and has accumulated 2 data snapshots since 2025. Oncology trials at this stage typically focus on safety, tolerability, and early efficacy signals.
Status Flow
Change History
2 versions recorded-
Oct 2025 — Present [monthly]
Not Yet Recruiting
-
Feb 2025 — Oct 2025 [monthly]
Not Yet Recruiting
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
Sponsor contact:
- Direction Générale de la Santé, France
- French National Cancer Institute (Institut National Du Cancer - France)
- Institut National de la Santé Et de la Recherche Médicale, France
- LABERCA - Laboratoire d'Etude des Résidus et Contaminants dans les Aliments
Data source: Institut National de la Santé Et de la Recherche Médicale, France
For direct contact, visit the study record on ClinicalTrials.gov .